Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats

Journal of Comparative Pathology

Volumn 150, Issue 2-3, 2014, Pages 194-197

  Beha, G ^a   Muscatello, L V ^a   Brunetti, B ^a   Asproni, P ^b   Millanta, F ^b   Poli, A ^b   Benazzi, C ^a   Sarli, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cat; Distant metastasis; Dog; Mammary tumour phenotype

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CAT; DISTANT METASTASIS; DOG; DRUG TARGETING; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CANIS FAMILIARIS; FELIDAE;

CAT; DISTANT METASTASIS; DOG; MAMMARY TUMOUR PHENOTYPE;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM METASTASIS; PHENOTYPE; RECEPTOR, ERBB-2;

EID: 84895896132     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2013.07.011     Document Type: Article

References (17)

1. Aleskandarany M.A., Green A.R., Benhasouna A.A., Barros F.F., Neal K., et al. Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer. Breast Cancer Research 2012, 14:R3.
2. Beha G., Brunetti B., Asproni P., Muscatello L.V., Millanta F., et al. Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?. BMC Veterinary Research 2012, 8:219.
3. Brunetti B., Asproni P., Beha G., Muscatello L.V., Millanta F., et al. Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis. Journal of Comparative Pathology 2013, 148:206-213.
4. Carey L.A. Directed therapy of subtypes of triple-negative breast cancer. Oncologist 2011, 15:49-56.
5. Fountzilas G., Dafni U., Bobos M., Batistatou A., Kotoula V., et al. Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel. PLoS One 2012, 7:e37946.
6. Gama A., Alves A., Schmitt F. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Archiv 2008, 453:123-132.
7. Gilbertson S.R., Kurzman I.D., Zachrau R.E., Hurvitz A.I., Black M.M., et al. Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Veterinary Pathology 1983, 20:127-142.
8. Ginn P.E., Mansell J.E.K.L., Rakich P.M. Skin and appendages. Pathology of Domestic Animals 2007, 779. Saunders Elsevier Press, Philadelphia. 5th Edit. M.G. Maxie (Ed.).
9. Kennecke H., Yerushalmi R., Woods R., Cheang M.C.U., Voduc D., et al. Metastatic behavior of breast cancer subtypes. Journal of Clinical Oncology 2010, 28:3271-3277.
10. Klopfleisch R., Lenze D., Hummel M., Gruber A.D. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer 2010, 10:618.
11. Lana S.E., Rutteman G.R., Withrow S.J. Tumors of the mammary gland. Withrow & MacEwen's Small Animal Clinical Oncology 2007, 631. Saunders Elsevier Press, Philadelphia. 4th Edit. S.J. Withrow, D.M. Vail (Eds.).
12. Lester S.C. The breast. Robbins' and Cotran's Pathologic Basis of Disease 2010, 1084-1085. Saunders Elsevier, Philadelphia. 8th Edit. V. Kumar, A. Abbas, N. Fausto, J.C. Aster (Eds.).
13. Misdorp W., Else R.W., Hellmén E., Lipscomb T.P. Histological Classification of Mammary Tumors of the Dog and Cat 1999, Armed Forces Institute of Pathology in Cooperation with the American Registry of Pathology and the World Health Organization Collaborating Centre for Worldwide Adherence on Comparative Oncology, Washington DC.
14. Sorlie T., Tibshirani R., Parker J., Hastie T., Marron J.S., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences USA 2003, 100:8418-8423.
15. Tavassoli F.A., Devilee P.L. World Health Organization classification of tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs 2003, IARC Press Ed., International Agency for Research on Cancer, Lyon, France.
16. Weigelt B., Hu Z., He X., Livasy C., Carey L.A., et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Research 2005, 65:9155-9158.
17. Wu J.M., Fackler M.J., Halushka M.K., Molavi D.W., Taylor M.E., et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clinical Cancer Research 2008, 10:1938-1946.